BRASS Participants
Researchers and Collaborators

Recent Publications

  • Effects of Achieving Target Measures in RA on Functional Status, Quality of Life and Resource Utilization: Analysis of Clinical Practice Data.  Abstract»
  • Development of a multimorbidity index: Impact on quality of life using a rheumatoid arthritis cohort. Abstract»
  • The impact of multimorbidity status on treatment response in rheumatoid arthritis patients initiating disease-modifying anti-rheumatic drugs. Abstract»
  • Perceptions of physical activity engagement among adults with rheumatoid arthritis and rheumatologists. Abstract»

The purpose of BRASS

The purpose of the Brigham and Women’s Rheumatoid Arthritis Sequential Study (BRASS), under the direction of Dr. Nancy Shadick and Dr. Michael Weinblatt, is to determine how genes can be used to predict whether Rheumatoid Arthritis (RA) will be mild or severe and to better understand how individuals respond to different drug treatments.
BRASS has over 1000 people diagnosed with RA who are patients at the Brigham & Women’s Hospital and who are followed in the clinic annually and sent questionnaires at six month intervals over a 15 year time span. Additionally, BRASS provides investigators with access to subsets of data as well as methodological support.

Find out more